Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aclarion, Inc. stock logo
ACON
Aclarion
$6.99
+0.6%
$7.22
$6.20
$3,499.51
$4.05M1.3412,103 shs29,563 shs
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
$6.47
-6.6%
$4.38
$2.01
$15.60
$12.45M5.313.47 million shs479,126 shs
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
$1.41
-4.1%
$1.66
$1.21
$2.55
$11.03M76.73104,921 shs31,960 shs
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
$1.04
-2.8%
$1.00
$0.62
$1.91
$7.32M1.11137,328 shs46,642 shs
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aclarion, Inc. stock logo
ACON
Aclarion
+0.58%-6.43%-6.99%-0.43%-99.76%
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
-6.64%+32.04%-5.13%+140.52%+32.66%
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-4.08%-12.96%-11.32%-23.37%-7.84%
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
-2.80%-23.53%+12.68%+19.54%+16.99%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aclarion, Inc. stock logo
ACON
Aclarion
1.4819 of 5 stars
3.03.00.00.00.00.01.3
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
0.319 of 5 stars
0.03.00.00.02.20.00.0
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
3.5106 of 5 stars
3.55.00.00.00.03.30.6
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
1.7152 of 5 stars
0.03.00.00.02.41.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aclarion, Inc. stock logo
ACON
Aclarion
2.00
Hold$11,758.50168,118.88% Upside
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
0.00
N/AN/AN/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
3.00
Buy$18.001,176.60% Upside
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ACON, BRTX, BGLC, and SSY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/30/2025
Aclarion, Inc. stock logo
ACON
Aclarion
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeModerate Buy
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aclarion, Inc. stock logo
ACON
Aclarion
$54.60K74.51N/AN/A$51.50 per share0.14
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
$9.51M1.22N/AN/A$4.63 per share1.40
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
$400K26.44N/AN/A$1.23 per share1.15
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
$31.09M0.24N/AN/A$2.00 per share0.52
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aclarion, Inc. stock logo
ACON
Aclarion
-$6.99MN/A0.00N/AN/A-12,227.10%-126.89%-106.61%8/13/2025 (Estimated)
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
-$1.60MN/A0.00N/A-22.85%-24.18%-20.14%N/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$8.98M-$1.47N/AN/AN/A-3,093.61%-129.47%-86.02%8/12/2025 (Estimated)
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
-$1.53M$0.247.43N/A3.20%-20.94%-16.09%N/A

Latest ACON, BRTX, BGLC, and SSY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Aclarion, Inc. stock logo
ACON
Aclarion
-$2.26N/AN/AN/AN/AN/A
8/12/2025Q2 2025
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$0.41N/AN/AN/A$0.34 millionN/A
5/15/2025Q1 2025
Aclarion, Inc. stock logo
ACON
Aclarion
-$1,447.20-$9.32+$1,437.88-$9.32$0.02 million$0.02 million
5/15/2025Q1 2025
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
N/A-$0.03N/A-$0.03N/AN/A
5/14/2025Q1 2025
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
-$0.32-$0.56-$0.24-$0.64$0.38 million$0.03 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aclarion, Inc. stock logo
ACON
Aclarion
N/AN/AN/AN/AN/A
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
N/AN/AN/AN/AN/A
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
N/AN/AN/AN/AN/A
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
N/AN/AN/AN/AN/A

Latest ACON, BRTX, BGLC, and SSY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/21/2025
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
special$0.107/29/20257/30/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aclarion, Inc. stock logo
ACON
Aclarion
N/A
21.68
21.68
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
N/A
4.19
3.44
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
N/A
2.24
2.24
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
N/A
4.06
3.62

Institutional Ownership

CompanyInstitutional Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
7.52%
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
18.85%
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
69.38%
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
23.67%

Insider Ownership

CompanyInsider Ownership
Aclarion, Inc. stock logo
ACON
Aclarion
0.77%
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
0.70%
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
25.50%
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
27.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aclarion, Inc. stock logo
ACON
Aclarion
7582,000578,000Not Optionable
BioNexus Gene Lab Corp. stock logo
BGLC
BioNexus Gene Lab
301.80 million1.78 millionNot Optionable
Biorestorative Therapies, Inc. stock logo
BRTX
Biorestorative Therapies
77.50 million5.59 millionNot Optionable
SunLink Health Systems, Inc. stock logo
SSY
SunLink Health Systems
1,3767.04 million5.08 millionNot Optionable

Recent News About These Companies

SunLink Health Systems Declares 10c Special Div
Regional Health Properties to merge with Sunlink Health Systems
Regional Health, SunLink Health to merge in all-stock transaction

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aclarion stock logo

Aclarion NASDAQ:ACON

$6.99 +0.04 (+0.58%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$7.03 +0.04 (+0.57%)
As of 08/1/2025 07:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aclarion, Inc., a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was incorporated in 2008 and is based in Broomfield, Colorado.

BioNexus Gene Lab stock logo

BioNexus Gene Lab NASDAQ:BGLC

$6.47 -0.46 (-6.64%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$6.56 +0.09 (+1.39%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.

Biorestorative Therapies stock logo

Biorestorative Therapies NASDAQ:BRTX

$1.41 -0.06 (-4.08%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.42 +0.01 (+0.71%)
As of 08/1/2025 04:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program (brtxDisc) includes a lead cell therapy candidate, BRTX-100, a product candidate formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow, which has completed Phase 1 clinical trials for use in the non-surgical treatment of painful lumbosacral disc disorders. The company is also developing Metabolic Program (ThermoStem), a cell-based therapy candidate that is in preclinical stage to target obesity and metabolic disorders using brown adipose derived stem cells to generate brown adipose tissue. In addition, it provides investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. BioRestorative Therapies, Inc. has a research and development agreement with Rohto Pharmaceutical Co., Ltd.; a research agreement with Pfizer, Inc.; and a research collaboration agreement with the University of Pennsylvania. The company was formerly known as Stem Cell Assurance, Inc. and changed its name to BioRestorative Therapies, Inc. in August 2011. The company was incorporated in 1997 and is based in Melville, New York.

SunLink Health Systems stock logo

SunLink Health Systems NYSE:SSY

$1.04 -0.03 (-2.80%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$1.12 +0.09 (+8.17%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SunLink Health Systems, Inc., through its subsidiaries, provides healthcare products and services in the southeastern United States. It operates in two segments, Healthcare Services and Pharmacy. The Healthcare Services segment owns and operates a 49-licensed-bed acute care hospital, which includes a 26-bed geriatric psychiatry unit; two clinics; and a 66-bed extended care and rehabilitation centre. This segment also provides information technology services; and owns five acers unimproved lands. The Pharmacy segment offers institutional pharmacy services consisting of provision of specialty and non-specialty pharmaceutical and biological products, such as nursing homes, assisted living facilities, behavioural and specialty hospitals, hospices, and correctional facilities; non-institutional pharmacy services, including private residences; and durable medical equipment products and services, including the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care, as well as retails pharmacy products and services. SunLink Health Systems, Inc. was incorporated in 1959 and is based in Atlanta, Georgia.